Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer: Long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099

Ricardo H. Alvarez, Daniel J. Booser, Massimo Cristofanilli, Aysegul A. Sahin, Eric A. Strom, Laura Guerra, Shu Wan Kau, Ana M. Gonzalez-Angulo, Gabriel N. Hortobagyi, Vicente Valero*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint Dive into the research topics of 'Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer: Long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099'. Together they form a unique fingerprint.

Medicine & Life Sciences